Ep. 207 - Are Cancer Detecting Blood Tests Ready For Prime Time? Here’s What The Galleri Test Can Actually Do
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Ep. 207 - Are Cancer Detecting Blood Tests Ready For Prime Time? Here’s What The Galleri Test Can Actually Do
-
ナレーター：
-
著者：
概要
Are cancer detecting blood tests finally ready for real world use? Dr. Dean Mitchell sits down with Dr. Eric Klein, a distinguished scientist at GRAIL and former Cleveland Clinic chair, to walk through the promise and the limits of the Galleri multi cancer early detection blood test. They break down how the test looks for cancer related DNA using methylation patterns, why it can often predict where a cancer started, and what happens next if a cancer signal is detected. You’ll also hear how Galleri fits alongside standard screenings like mammograms, colonoscopy, PSA, and Cologuard, plus a clear explanation of sensitivity versus positive predictive value and why false positives matter. They also explore who may benefit most from testing, why age is the biggest risk factor, what the real false positive rate looks like, and how long a negative result may offer peace of mind.
Contact Dr. Mitchell:
Email: care@mitchellmedicalgroup.com
Website
YouTube
Order your copy of Dr. Mitchell’s latest book, Conquering Candida, here.